AAAP 37th Annual Meeting and Scientific Symposium

Venue

The Peabody Memphis

Format

in-person

Registration

$100 – $1,250

Early-bird deadline

October 1, 2026

Official website → · Add dates & deadlines to calendar

Registration pricing

Who this conference is for

The home meeting for addiction psychiatry: practical, collegial, and small enough to actually meet people. Strong fit for anyone treating substance use disorders, including buprenorphine-waivered generalists.

At a glance

Primary audience

Psychiatrists — Addiction psychiatrists and addiction-medicine clinicians; strong fellowship presence

Orientation

Mostly clinical

Industry funding

Moderate industry presence

Typical attendance

~800

Program highlights

6 of 20 major sessions from the official program — excludes posters, exhibits, and social events.

• SymposiumSymposiaBeyond Abstinence: Measuring What Matters in Cannabis Use Disorder Medication Development

  Christina Brezing, MD · Frances Levin, MD · Margaret Haney, PhD · John Mariani, MD

  Argues for moving beyond abstinence as the sole endpoint in cannabis use disorder trials, discussing reduction-based and patient-centered outcome measures.

• SymposiumSymposiaFrom Metabolism to Addictions: Repurposing GLP-1 Therapies for Alcohol and Other Substance Use Disorders

  Lorenzo Leggio, MD, PhD · Joji Suzuki, MD · Luba Yammine, PhD · Manish Jha, MD

  Surveys preclinical and emerging clinical evidence for GLP-1 receptor agonists as candidate treatments for alcohol and other substance use disorders.

• SymposiumSymposiaNeuromodulation to Treat Addictions: What's Available and What's in the Pipeline

  Manish Jha, MD · Kathleen Brady, MD · Hamed Ekhtiari, MD, PhD · Gregory Sahlem, MD · Brian Mickey, MD, PhD

  Reviews current and investigational neuromodulation techniques for substance use disorders, including rTMS and focused ultrasound.

• SymposiumMini SymposiumTobacco Use and Its Impact on Psychiatric Symptoms and the Recovery from Other Substance Use Disorders

  Maher Karam Hage, MD · Jill Williams, MD · Brian Hurley, MD · Tony George, MD

  Examines how ongoing tobacco use interacts with psychiatric symptoms and recovery from other substance use disorders.

• LectureMedical UpdateHormone Therapy for Perimenopause and Menopause

  Pallavi Khanna, MD

  Evidence-based update on hormone replacement therapy for perimenopausal and menopausal patients, covering indications, contraindications, risk stratification, formulations, and monitoring.

• WorkshopWorkshopsAddiction, Hope, and Recovery in Tolkien's the Lord of the Rings

  Lisa Terris, PhD · James Berry, DO

  Uses Tolkien's fiction as a lens for discussing addiction, hope, and recovery themes with patients and trainees.

See the full program — all 20 sessions & speakers →

Program details verified August 20, 2026; sessions and speakers may change — confirm on the official site.